Specific destruction of allogeneic tumor cells in vivo by a bismuth-212 immunotoxin.
Stuart
F P
FP
University of Chicago, IL 60637.
Perdrizet
G
G
Steranka
B
B
Buckingham
M
M
Lopes
D
D
Alvarez
V
V
Rodwell
J
J
McKearn
T
T
Hines
J
J
Atcher
R
R
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001729:Bismuth / Q000627:therapeutic use*; D000922:Immunotoxins / Q000627:therapeutic use*; D008223:Lymphoma / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D009368:Neoplasm Transplantation; D011868:Radioisotopes / Q000627:therapeutic use*; D051381:Rats; D011914:Rats, Inbred BN; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D000922:Immunotoxins; D011868:Radioisotopes; D001729:Bismuth